What is the current stock price of Pharmena S.A. (PHR.WA)?

As of the latest market data, Pharmena S.A. (PHR.WA) is trading at $0.00. The stock has seen a loss of undefined% today.

Does Pharmena S.A. (PHR.WA) pay a dividend?

Based on current data, Pharmena S.A. does not have a confirmed active dividend policy.

What is the market cap of Pharmena S.A.?

The current market capitalization of Pharmena S.A. (PHR.WA) is approximately unavailable.

PHR.WA

Pharmena S.A.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

Pharmena S.A., a biotechnology company, manufactures and sells active ingredients in various areas of medicines in Poland and internationally. The company offers dermatological cosmetics, including skin, hair, and nail care products, as well as dietary supplement for atherosclerosis prophylaxis. It offers its products under the Menavitin, Dermena, Allerco, and Thermi names. The company is developing 1-MNA, an anti-atherosclerosis drug which is under phase II clinical trial. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. Pharmena S.A. is a subsidiary of Pelion S.A.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2008-08-01

Beta

0.63

Websitewww.pharmena.eu↗